Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Bvlgari, the Italian luxury brand, has today announced plans to support research into COVID-19 and vaccine development at Oxford University.

© Sean Elias

The new relationship comes as part of the brand’s commitment to better preventing pandemics now and in the future, through philanthropic donations. This gift will support Oxford research in two key areas; by purchasing boundary-pushing scientific equipment that will help to speed up vaccine development, and financing the studies of some of the world’s most talented researchers engaged in the field.

The collaboration was announced during a live webinar hosted by Jean-Christophe Babin, President and CEO of Bvlgari and Professor Sarah Gilbert, Professor of Vaccinology at the Jenner Institute, University of Oxford.

Professor Sarah Gilbert, Professor of Vaccinology at the University of Oxford, said: 'For us to continue to make world-leading advances against infectious diseases we need more excellent young scientists to join the field of vaccinology, and access to the most up to date equipment for our laboratories. This generous gift from Bvlgari addresses both of these needs, and will continue to have an impact for many years to come.'

Read the full story on the University of Oxford website

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.